/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
First-of-its-Kind Consumer Benefits Coverage Index Illustrates Benefits Spending Patterns Across U.S.
Reading Time: 2 minutes
Benefitfocus, Inc. (NASDAQ: BNFT), a leading cloud-based benefits management platform and services provider, today announced the release of the Consumer Benefits Coverage Index
(“the Index”). The Index creates a model for evaluating how adequately a consumer is protected through the employer-based benefits they’ve purchased. The value of the Index lies not only in serving as a benchmark for consumers to compare their own benefits coverage to that of their peers, but also to provide greater awareness on how they could better protect themselves and their families. For its initial findings, Benefitfocus examined a representative sample of U.S. consumers and determined that the average consumer may not be adequately protected in key areas, and that there is opportunity for additional education when it comes to benefit selection.
“We provide insight for the entire benefits industry comprised of employers, brokers, carriers and product suppliers into the purchasing behavior and coverage gaps present among consumers,” said Ray August, President & CEO, Benefitfocus. “The Index processes millions of enrollment transactions from our platform and transforms them into a simple model for employers and consumers to evaluate the fitness of their benefit decisions and raise their benefits IQ.”
Created by Benefitfocus using its proprietary, annually recurring research (previously published in the State of Employee Benefits reports), the Index draws on anonymized, actual benefits enrollment data pulled from the BENEFITFOCUS® Platform. The Index examines consumers’ spending decisions specific to voluntary benefits, defined for the purposes of the Index as those non-medical benefits offered through an employer but paid for partially or solely by the consumer. These benefits span across three product categories—health (e.g., dental, vision or health advocacy), wealth (e.g., life insurance or health spending accounts) and lifestyle (e.g., identity theft protection or pet insurance). Each benefits category in the Index is scored on a scale from 0 to 100 (with an aggregate score range of 0-300), reflecting the average spend by a consumer in these categories relative to their peer group. Scores can fall in one of three ranges that approximate optimal and sub-optimal coverage based on how similar or dissimilar an individual’s coverage is to their peer group.
“Our goal is to use our massive data intelligence to drive greater awareness of the benefits purchasing habits of working Americans,” said Jennifer Clark, Director of Artificial Intelligence Strategy at Benefitfocus. “For employers, this data set may help them optimize their benefits offerings based on their employee demographics. For consumers, the Index sheds much-needed light into purchasing habits and may lead to a better understanding of what makes sense for individuals based on their salary, age, etc. – which are constantly changing. The Index provides a framework to refer to when considering coverage and life transitions.”
To learn more about CBCI visit https://www.benefitfocus.com/consumer-benefits-coverage-index.
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks agoIMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week agoInnocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week agoCuraleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week agoCannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE2 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
